Cargando…

Multi-label classification for multi-drug resistance prediction of Escherichia coli

Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria. It has become a serious problem to public health, as MDR can lead to the failure of treatment of patients. MDR is typically the result o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yunxiao, Chakraborty, Trinad, Doijad, Swapnil, Falgenhauer, Linda, Falgenhauer, Jane, Goesmann, Alexander, Schwengers, Oliver, Heider, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918850/
https://www.ncbi.nlm.nih.gov/pubmed/35317240
http://dx.doi.org/10.1016/j.csbj.2022.03.007
_version_ 1784668817869242368
author Ren, Yunxiao
Chakraborty, Trinad
Doijad, Swapnil
Falgenhauer, Linda
Falgenhauer, Jane
Goesmann, Alexander
Schwengers, Oliver
Heider, Dominik
author_facet Ren, Yunxiao
Chakraborty, Trinad
Doijad, Swapnil
Falgenhauer, Linda
Falgenhauer, Jane
Goesmann, Alexander
Schwengers, Oliver
Heider, Dominik
author_sort Ren, Yunxiao
collection PubMed
description Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria. It has become a serious problem to public health, as MDR can lead to the failure of treatment of patients. MDR is typically the result of mutations and the accumulation of multiple resistance genes within a single cell. Machine learning methods have a wide range of applications for AMR prediction. However, these approaches typically focus on single drug resistance prediction and do not incorporate information on accumulating antimicrobial resistance traits over time. Thus, identifying multi-drug resistance simultaneously and rapidly remains an open challenge. In our study, we could demonstrate that multi-label classification (MLC) methods can be used to model multi-drug resistance in pathogens. Importantly, we found the ensemble of classifier chains (ECC) model achieves accurate MDR prediction and outperforms other MLC methods. Thus, our study extends the available tools for MDR prediction and paves the way for improving diagnostics of infections in patients. Furthermore, the MLC methods we introduced here would contribute to reducing the threat of antimicrobial resistance and related deaths in the future by improving the speed and accuracy of the identification of pathogens and resistance.
format Online
Article
Text
id pubmed-8918850
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-89188502022-03-21 Multi-label classification for multi-drug resistance prediction of Escherichia coli Ren, Yunxiao Chakraborty, Trinad Doijad, Swapnil Falgenhauer, Linda Falgenhauer, Jane Goesmann, Alexander Schwengers, Oliver Heider, Dominik Comput Struct Biotechnol J Research Article Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria. It has become a serious problem to public health, as MDR can lead to the failure of treatment of patients. MDR is typically the result of mutations and the accumulation of multiple resistance genes within a single cell. Machine learning methods have a wide range of applications for AMR prediction. However, these approaches typically focus on single drug resistance prediction and do not incorporate information on accumulating antimicrobial resistance traits over time. Thus, identifying multi-drug resistance simultaneously and rapidly remains an open challenge. In our study, we could demonstrate that multi-label classification (MLC) methods can be used to model multi-drug resistance in pathogens. Importantly, we found the ensemble of classifier chains (ECC) model achieves accurate MDR prediction and outperforms other MLC methods. Thus, our study extends the available tools for MDR prediction and paves the way for improving diagnostics of infections in patients. Furthermore, the MLC methods we introduced here would contribute to reducing the threat of antimicrobial resistance and related deaths in the future by improving the speed and accuracy of the identification of pathogens and resistance. Research Network of Computational and Structural Biotechnology 2022-03-10 /pmc/articles/PMC8918850/ /pubmed/35317240 http://dx.doi.org/10.1016/j.csbj.2022.03.007 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Ren, Yunxiao
Chakraborty, Trinad
Doijad, Swapnil
Falgenhauer, Linda
Falgenhauer, Jane
Goesmann, Alexander
Schwengers, Oliver
Heider, Dominik
Multi-label classification for multi-drug resistance prediction of Escherichia coli
title Multi-label classification for multi-drug resistance prediction of Escherichia coli
title_full Multi-label classification for multi-drug resistance prediction of Escherichia coli
title_fullStr Multi-label classification for multi-drug resistance prediction of Escherichia coli
title_full_unstemmed Multi-label classification for multi-drug resistance prediction of Escherichia coli
title_short Multi-label classification for multi-drug resistance prediction of Escherichia coli
title_sort multi-label classification for multi-drug resistance prediction of escherichia coli
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918850/
https://www.ncbi.nlm.nih.gov/pubmed/35317240
http://dx.doi.org/10.1016/j.csbj.2022.03.007
work_keys_str_mv AT renyunxiao multilabelclassificationformultidrugresistancepredictionofescherichiacoli
AT chakrabortytrinad multilabelclassificationformultidrugresistancepredictionofescherichiacoli
AT doijadswapnil multilabelclassificationformultidrugresistancepredictionofescherichiacoli
AT falgenhauerlinda multilabelclassificationformultidrugresistancepredictionofescherichiacoli
AT falgenhauerjane multilabelclassificationformultidrugresistancepredictionofescherichiacoli
AT goesmannalexander multilabelclassificationformultidrugresistancepredictionofescherichiacoli
AT schwengersoliver multilabelclassificationformultidrugresistancepredictionofescherichiacoli
AT heiderdominik multilabelclassificationformultidrugresistancepredictionofescherichiacoli